Br J Cancer. 1973 Oct;28(4):316-21.

The inhibition by aspirin and indomethacin of osteolytic tumor deposits and hypercalcaemia in rats with Walker tumour, and its possible application to human breast cancer.

Powles TJ, Clark SA, Easty DM, Easty GC, Neville AM.

Abstract

Walker carcinosarcoma cells cause in vitro osteolysis which may be inhibited by aspirin. In the rat, this tumour produces osteolytic bone deposits and hypercalcaemia, both of which can be prevented by aspirin and indomethacin, whereas soft tissue tumour deposits are unaffected by these drugs. Some human breast tumours cause in vitro osteolysis which may be inhibited by aspirin.

PMID:: 4759939; [PubMed - indexed for MEDLINE]
PMCID: PMC2008894

Free PMC Article

LinkOut - more resources

Full Text Sources

Medical

Breast Cancer - MedlinePlus Health Information

Molecular Biology Databases

Libraries

LinkOut Holdings

Supplemental Content

Related citations

Breast-cancer osteolysis, bone metastases, and anti-osteolytic effect of aspirin. [Lancet. 1976]
Breast-cancer osteolysis, bone metastases, and anti-osteolytic effect of aspirin.
Powles TJ, Dowsett M, Easty GC, Easty DM, Neville AM. Lancet. 1976 Mar 20; 1(7960):608-10.
Failure of indomethacin to reduce hypercalcemia in patients with breast cancer. [Prostaglandins. 1976]
Failure of indomethacin to reduce hypercalcemia in patients with breast cancer.
Coombes RC, Neville AM, Bondy PK, Powles TJ. Prostaglandins. 1976 Dec; 12(6):1027-35.
In vitro osteolysis by human breast tumours. [Proc R Soc Med. 1977]
In vitro osteolysis by human breast tumours.
Easty GC, Dowsett M, Powles TJ, Easty DM, Gazet JC, Neville AM. Proc R Soc Med. 1977 Mar; 70(3):191-5.
Review Pamidronate. A review of its use in the management of osteolytic bone metastases, tumour-induced hypercalcaemia and Paget's disease of bone. [Drugs Aging. 1998]
Review Pamidronate. A review of its use in the management of osteolytic bone metastases, tumour-induced hypercalcaemia and Paget's disease of bone.
Coukell AJ, Markham A. Drugs Aging. 1998 Feb; 12(2):149-68.
Review Mechanisms for the development of bone metastases and hypercalcaemia in patients with breast cancer. [Proc R Soc Med. 1977]
Review Mechanisms for the development of bone metastases and hypercalcaemia in patients with breast cancer.
Powles TJ. Proc R Soc Med. 1977 Mar; 70(3):199-201.

See reviews... See all...

Cited by 23 PubMed Central articles

Review Breast cancer metastasis to the bone: mechanisms of bone loss. [Breast Cancer Res. 2010]
Review Breast cancer metastasis to the bone: mechanisms of bone loss.
Chen YC, Sosnoski DM, Mastro AM. Breast Cancer Res. 2010; 12(6):215. Epub 2010 Dec 16.
Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026]. [Breast Cancer Res. 2006]
Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026].
Powles T, Paterson A, McCloskey E, Schein P, Scheffler B, Tidy A, Ashley S, Smith I, Ottestad L, Kanis J. Breast Cancer Res. 2006; 8(2):R13. Epub 2006 Mar 15.
Effects of sulindac on sporadic colorectal adenomatous polyps. [Gut. 1997]
Effects of sulindac on sporadic colorectal adenomatous polyps.
Matsuhashi N, Nakajima A, Fukushima Y, Yazaki Y, Oka T. Gut. 1997 Mar; 40(3):344-9.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

The inhibition by aspirin and indomethacin of osteolytic tumor deposits and hype...
The inhibition by aspirin and indomethacin of osteolytic tumor deposits and hypercalcaemia in rats with Walker tumour, and its possible application to human breast cancer.
Br J Cancer. 1973 Oct ;28(4):316-21.

PubMed
ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a med...
ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling.
EMBO J. 1997 Apr 1 ;16(7):1647-55.

PubMed
Diet during adolescence and risk of breast cancer among young women.
Diet during adolescence and risk of breast cancer among young women.
J Natl Cancer Inst. 1998 Feb 4 ;90(3):226-33.

PubMed
Fluorouracil: biochemistry and pharmacology.
Fluorouracil: biochemistry and pharmacology.
J Clin Oncol. 1988 Oct ;6(10):1653-64.

PubMed
Synergistic interaction of transforming growth factor alpha and c-myc in mouse m...
Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
Cell Growth Differ. 1995 Jun ;6(6):737-48.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

The inhibition by aspirin and indomethacin of osteolytic tumor deposits and hypercalcaemia in rats with Walker tumour, and its possible application to human breast cancer.

Abstract

MeSH Terms, Substances

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Molecular Biology Databases

Libraries

Supplemental Content

Related citations

Cited by 23 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information